COM:APOLLOMICSINC
Apollomics, Inc.
- Stock
market
STOCKSindustry
Biopharmaceuticalswebsite
apollomicsinc.comcrunchbase
cbt-pharmaceuticalsipo date
Nov 26, 2021
Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active, small molecul...Show More